Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Adipic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.41 |
| ▸ | PPARG | P37231 | 7/20 | 0.41 |
| ▸ | PPARD | Q03181 | 7/20 | 0.41 |
| ▸ | PPARA | Q07869 | 7/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.41 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adipic Acid SCHEMBL27539142 | 1.00 | LMNA (0.46) | LMNATSHRNFKB1PMP22AKR1B1 | |
| Sebacic Acid SCHEMBL2344968 | 0.98 | TSHR (0.48) | LMNATSHRNFKB1PMP22AKR1B1 | |
| Sebacic Acid SCHEMBL8067661 | 0.98 | TSHR (0.48) | LMNATSHRNFKB1PMP22AKR1B1 | |
| Succinic Acid SCHEMBL28499250 | 0.91 | EGLN1 (0.41) | LMNAALDH1A1SLC22A6OR51E2BBOX1 | |
| Succinic Acid SCHEMBL2342959 | 0.91 | EGLN1 (0.41) | LMNAALDH1A1SLC22A6OR51E2BBOX1 | |
| Palmitic Acid SCHEMBL28380297 | 0.91 | GPR84 (0.59) | LMNATSHRAKR1B1GPR84PPARG | |
| Stearic Acid SCHEMBL27656171 | 0.91 | GPR84 (0.59) | LMNATSHRAKR1B1GPR84PPARG | |
| Sebacic Acid SCHEMBL9506634 | 0.88 | TSHR (0.39) | LMNATSHRNFKB1PMP22AKR1B1 | |
| Beta-Alanine SCHEMBL27842605 | 0.84 | LMNA (0.37) | LMNATSHRNFKB1HDAC11ALDH1A1 | |
| Acetic Acid SCHEMBL986871 | 0.80 | FFAR3 (0.38) | TSHRNFKB1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107921221-B | Assembly for syringe, prefilled syringe, seal cap for outer cylinder, and assembly package for syringe | 泰尔茂株式会社 | 2021-07-20 | — | — | CN | disclosed |
| US-20040122270-A1 | In-situ polymerization of monoethylenically unsaturated monomers with secondary amines | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-24 | — | — | US | disclosed |
| EP-1428838-A1 | In situ-polymerization of monoethylenically unsaturated monomers with secondary amines | Bayer MaterialScience AG (DE) | 2004-06-16 | — | — | EP | disclosed |
| EP-1428839-A1 | In-situ polymerization of monoethylenically unsaturated monomers with secondary amines | Bayer MaterialScience AG (DE) | 2004-06-16 | — | — | EP | disclosed |
| EP-1052112-B1 | Color developer composition, aqueous dispersion, recording sheet and color developing ink | MITSUI CHEMICALS INC (JP) | 2004-02-04 | — | — | EP | disclosed |
| US-6686424-B2 | USE IN RADICAL POLYMERIZATION; REACTING AN OXIDIZING AGENT WITH A STERICALLY HINDERED SECONDARY AMINE TO PRODUCE A NITROXY RADICAL; ADDING TO THE NITROXY RADICAL ONE OR MORE VINYL MONOMER | BAYER AKTIENGESELLSCHAFT (DE) | 2004-02-03 | — | — | US | disclosed |
| EP-1375457-A1 | One-pot process for the preparation of functionalized alkoxyamines | Bayer Aktiengesellschaft (DE) | 2004-01-02 | — | — | EP | disclosed |
| EP-1375476-A1 | A new process for the synthesis of alkoxyamines active in controlled radical polymerization | Bayer Aktiengesellschaft (DE) | 2004-01-02 | — | — | EP | disclosed |
| US-20040002606-A1 | Process for the synthesis for alkoxy amines and their use in controlled radical polymerization | BAYER AKTIENGESELLSCHAFT (DE) | 2004-01-01 | — | — | US | disclosed |
| US-20030236368-A1 | PREPARATION OF FUNCTIONALIZED ALKOXYAMINE INITIATOR AND ITS USE | BAYER AKTIENGESELLSCHAFT (DE) | 2003-12-25 | — | — | US | disclosed |
| US-6383982-B1 | DYE DEVELOPERS FOR COLORING, METAL SALICYLATE AND POLYESTER POLYOLS WITH CARBONATE OR ESTER | MITSUI CHEMICALS, INC. (JP) | 2002-05-07 | — | — | US | disclosed |
| EP-1052112-A2 | Color developer composition, aqueous dispersion, recording sheet and color developing ink | Mitsui Chemicals, Inc. (JP) | 2000-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236368-A1 | PREPARATION OF FUNCTIONALIZED ALKOXYAMINE INITIATOR AND ITS USE | NOS1, NOS2, CBR1 | LMNA 2253/4885TSHR 3966/4885NFKB1 785/4885 |
| US-20040002606-A1 | Process for the synthesis for alkoxy amines and their use in controlled radical polymerization | ALKBH3, MAOB, ALKBH1 | LMNA 2174/4885TSHR 4237/4885NFKB1 1356/4885 |
| US-20040122270-A1 | In-situ polymerization of monoethylenically unsaturated monomers with secondary amines | ALOX5, PARG, FASN | LMNA 515/4885TSHR 4635/4885NFKB1 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.